Next generation sequencing (NGS) studies have shown that mutations in TCF3 or ID3 occur in 70 % of sporadic and immunodeficiency-related BL and 40 % of endemic BL, though these rates vary between studies [6,53,57]. The gene discussed is ID3; the disease is Burkitt lymphoma.